Argentina vs Mexico: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Argentina
79.0%
in 2025
Mexico
78.0%
in 2025
Argentina rank
121st
Mexico rank
123rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Argentina
- Mexico
How they compare
Argentina currently reports 79.0% against 78.0% in Mexico, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Mexico ahead.
Argentina ranks 121st and Mexico ranks 123rd of 194 countries.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 30.0% | 30.0% | Mexico |
| 2010s | 62.6% | 91.8% | 29.2% | Mexico |
| 2020s | 77.0% | 79.3% | 2.3% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Argentina or Mexico?
- Argentina, at 79.0% against 78.0% in Mexico as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Argentina and Mexico?
- 1.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Mexico?
- 18 years are reported by both, from 2008 to 2025.
- How do Argentina and Mexico rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Argentina ranks 121st and Mexico ranks 123rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.